BONUS!!! Download part of Pass4Test CIC dumps for free: https://drive.google.com/open?id=1OyRA030-cdY1rTDse7id7_BONkkd1iLD
These experts are committed and work together and verify each CIC exam question so that you can get the real, valid, and updated CBIC Certified Infection Control Exam (CIC) exam practice questions all the time. So you do not need to get worried, countless CIC exam candidates have already passed their dream CBIC CIC Certification Exam and they all got help from real, valid, and error-free CIC exam practice questions. So you also need to think about your future and advance your career with the badge of CIC certification exam.
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Education and Research | 6-9% | |
| Topic 2: Environment of Care | 10-13% | |
| Topic 3: Employee/Occupational Health | 10-13% | |
| Topic 4: Cleaning, Sterilization, Disinfection, Asepsis | 10-13% | |
| Topic 5: Preventing/Controlling the Transmission of Infectious Agents | 17-19% | |
| Topic 6: Identification of Infectious Disease Processes | 17-19% | |
| Topic 7: Management and Communication | 10-13% | |
| Topic 8: Surveillance and Epidemiologic Investigation | 22-26% |
>> Practice CIC Test Online <<
We are confident in the ability of CIC exam torrent and we also want to our candidates feel confident in our certification exam materials. For this reason, all questions and answers in our CIC valid dumps are certified and tested by our senior IT professionals. And we guarantee that if you failed the certification exam with our CIC Pdf Torrent, we will get your money back to reduce your loss.
NEW QUESTION # 110
The infection preventionist (IP) is assisting pharmacists in investigating medication contamination at the hospital's compounding pharmacy. As part of the medication recall process, the IP should:
Answer: B
Explanation:
The scenario involves an infection preventionist (IP) assisting pharmacists in addressing medication contamination at the hospital's compounding pharmacy, with a focus on the medication recall process. The IP' s role is to apply infection control expertise to mitigate risks, guided by the Certification Board of Infection Control and Epidemiology (CBIC) principles and best practices. The recall process requires a systematic approach to identify, contain, and resolve the issue, and the "first" or most critical step must be determined.
Let's evaluate each option:
A). Have laboratory culture all medication: Culturing all medication to confirm contamination is a valuable step to identify affected batches and guide the recall. However, this is a resource-intensive process that depends on first understanding the scope and source of the problem. Without identifying the potential source of contamination, culturing all medication could be inefficient and delay the recall. This step is important but secondary to initial investigation.
B). Inspect for safe injection practices: Inspecting for safe injection practices (e.g., single-use vials, proper hand hygiene, sterile technique) is a critical infection control measure, especially in compounding pharmacies where contamination often arises from procedural errors (e.g., reuse of syringes, improper cleaning). While this is a proactive step to prevent future contamination, it addresses ongoing practices rather than the immediate recall process for the current contamination event. It is a complementary action but not the first priority.
C). Identify the potential source of contamination: Identifying the potential source of contamination is the foundational step in the recall process. This involves investigating the compounding environment (e.g., water quality, equipment, personnel practices), raw materials, and production processes to pinpoint where the contamination occurred (e.g., bacterial ingress, cross-contamination). The CBIC emphasizes root cause analysis as a key infection prevention strategy, enabling targeted recalls, corrective actions, and prevention of recurrence. This step is essential before culturing, inspecting, or notifying patients, making it the IP's primary responsibility in this context.
D). Inform all discharged patients of potential medication contamination: Notifying patients is a critical step to ensure public safety and allow for medical follow-up if they received contaminated medication. However, this action requires prior identification of the contaminated batches and their distribution, which depends on determining the source and confirming the extent of the issue. Premature notification without evidence could cause unnecessary alarm and is not the first step in the recall process.
The best answer is C, as identifying the potential source of contamination is the initial and most critical step in the medication recall process. This allows the IP to collaborate with pharmacists to trace the contamination, define the affected products, and guide subsequent actions (e.g., culturing, inspections, notifications). This aligns with CBIC's focus on systematic investigation and risk mitigation in healthcare-associated infection events.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which includes identifying sources of contamination in healthcare settings.
CBIC Examination Content Outline, Domain V: Management and Communication, which emphasizes root cause analysis during outbreak investigations.
CDC Guidelines for Safe Medication Compounding (2022), which recommend identifying contamination sources as the first step in a recall process.
NEW QUESTION # 111
Which of the following factors influences the growth of microorganisms in a multi-dose medication vial?
Answer: C
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies aseptic technique as the most critical factor influencing the growth of microorganisms in multi-dose medication vials. Multi-dose vials are designed for repeated entry and therefore carry an inherent risk of contamination if proper infection prevention practices are not strictly followed.
Microbial growth in a vial most often results from breaks in aseptic technique during medication preparation or access. This includes failure to disinfect the rubber septum with alcohol prior to vial entry, reuse of needles or syringes, use of contaminated hands or gloves, and improper storage after opening. Once microorganisms are introduced into a vial, preservatives may not fully inhibit growth, especially if contamination levels are high or storage conditions are suboptimal.
Syringe size (Option A) does not influence microbial growth. Patient comorbidities (Option C) affect infection risk in the patient but have no impact on contamination within the vial itself. Administration techniques (Option D) relate to how medication is delivered to the patient, not how organisms enter or proliferate within the medication container.
The Study Guide emphasizes that strict adherence to aseptic technique-including hand hygiene, use of sterile needles and syringes, septum disinfection, and proper storage-is essential to prevent contamination of multi- dose vials. Numerous healthcare-associated outbreaks have been traced to failures in these practices.
For the CIC exam, this question reinforces that aseptic technique is the primary determinant of microbial contamination and growth in medication vials, making it the correct answer.
NEW QUESTION # 112
Steam sterilization should be validated with which of the following organisms?
Answer: A
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly states that steam sterilization (moist heat sterilization) must be validated using biological indicators containing Geobacillus stearothermophilus spores. This organism is selected because its spores are highly resistant to moist heat, making them an ideal challenge organism for assessing the effectiveness of steam sterilization processes.
Biological indicators are used to confirm that sterilization conditions-such as temperature, pressure, and exposure time-are sufficient to achieve microbial inactivation. Geobacillus stearothermophilus thrives at high temperatures and demonstrates strong resistance to steam, so if these spores are destroyed, it provides high confidence that other less-resistant microorganisms, including bacteria, viruses, and fungi, have also been eliminated.
The other options are incorrect for steam sterilization validation. Staphylococcus aureus is a vegetative bacterium and is far less resistant than bacterial spores. Bacillus anthracis is not used as a biological indicator due to safety concerns and lack of standardization. Bacillus atrophaeus is used as the biological indicator for dry heat and ethylene oxide sterilization, not steam.
Understanding which biological indicators correspond to specific sterilization modalities is a high-yield topic on the CIC exam and is essential for ensuring compliance with evidence-based sterilization and disinfection standards.
=======
NEW QUESTION # 113
What rate is expressed by the number of patients who acquire infections over a specified time period divided by the population at risk of acquiring an infection during that time period?
Answer: C
Explanation:
Theincidence ratemeasuresnew cases of infection in a population over a defined time periodusing the formula:
Why the Other Options Are Incorrect?
* B. Disease specific- Refers to infectionscaused by a particular pathogen, not the general rate of new infections.
* C. Point prevalence- Measuresexisting cases at a specific point in time, not new cases.
* D. Period prevalence- Includesboth old and new cases over a set period, unlike incidence, which only considers new cases.
CBIC Infection Control Reference
APIC definesincidence rate as the number of new infections in a population over a given period.
NEW QUESTION # 114
An infection preventionist in the role of educator is teaching risk reduction activities to patients and families.
For which of the following groups is the pneumococcal vaccine MOST appropriate?
Answer: B
Explanation:
The pneumococcal vaccine is designed to protect against infections caused by Streptococcus pneumoniae, a bacterium responsible for diseases such as pneumonia, meningitis, and bacteremia. The appropriateness of this vaccine depends on the population's risk profile, particularly their susceptibility to invasive pneumococcal disease (IPD). The Certification Board of Infection Control and Epidemiology (CBIC) highlights the role of infection preventionists as educators in promoting vaccination as a key risk reduction strategy, aligning with the "Education and Training" domain (CBIC Practice Analysis, 2022). The Centers for Disease Control and Prevention (CDC) provides specific guidelines on pneumococcal vaccination, recommending it for individuals at higher risk due to underlying medical conditions or immunologic status.
Option A, asplenic patients, refers to individuals who have had their spleen removed (e.g., due to trauma or disease) or have a nonfunctional spleen (e.g., in sickle cell disease). The spleen plays a critical role in clearing encapsulated bacteria like Streptococcus pneumoniae from the bloodstream. Without a functioning spleen, these patients are at significantly increased risk of overwhelming post-splenectomy infection (OPSI), with pneumococcal disease being a leading cause. The CDC and Advisory Committee on Immunization Practices (ACIP) strongly recommend pneumococcal vaccination, including both PCV15/PCV20 and PPSV23, for asplenic patients, making this group the most appropriate for the vaccine in this context. The infection preventionist should prioritize educating these patients and their families about the vaccine's importance and timing.
Option B, international travelers, may benefit from various vaccines depending on their destination (e.g., yellow fever or typhoid), but pneumococcal vaccination is not routinely recommended unless they have specific risk factors (e.g., asplenia or chronic illness) or are traveling to areas with high pneumococcal disease prevalence. This group is not inherently a priority for pneumococcal vaccination. Option C, immunocompromised newborns, includes infants with congenital immunodeficiencies or other conditions, who may indeed require pneumococcal vaccination as part of their routine immunization schedule (e.g., PCV15 or PCV20 starting at 2 months). However, newborns are generally covered under universal childhood vaccination programs, and the question's focus on "MOST appropriate" suggests a group with a more specific, elevated risk, which asplenic patients fulfill. Option D, patients in behavioral health settings, may have varied health statuses, but this group is not specifically targeted for pneumococcal vaccination unless they have additional risk factors (e.g., chronic diseases), making it less appropriate than asplenic patients.
The CBIC emphasizes tailoring education to high-risk populations, and the CDC's Adult and Pediatric Immunization Schedules (2023) identify asplenic individuals as a top priority for pneumococcal vaccination due to their extreme vulnerability. Thus, the infection preventionist should focus on asplenic patients as the group for whom the pneumococcal vaccine is most appropriate.
References:
* CBIC Practice Analysis, 2022.
* CDC Adult Immunization Schedule, 2023.
* CDC Pediatric Immunization Schedule, 2023.
* ACIP Recommendations for Pneumococcal Vaccination, 2022.
NEW QUESTION # 115
......
In order to cater to the different needs of people from different countries in the international market, we have prepared three kinds of versions of our CIC learning questions in this website. And we can assure you that you will get the latest version of our CIC Training Materials for free from our company in the whole year after payment on CIC practice quiz. Last but not least, we will provide the most considerate after sale service for our customers on our CIC exam dumps.
Top CIC Exam Dumps: https://www.pass4test.com/CIC.html
BTW, DOWNLOAD part of Pass4Test CIC dumps from Cloud Storage: https://drive.google.com/open?id=1OyRA030-cdY1rTDse7id7_BONkkd1iLD